In silico frameworks for systematic pre-clinical screening of potential anti-leukemia therapeutics.
Leukemia is a collection of highly heterogeneous cancers that arise from neoplastic transformation and clonal expansion of immature hematopoietic cells. Post-treatment recurrence is high, especially among elderly patients, thus necessitating more effective treatment modalities. Development of novel anti-leukemic compounds relies heavily on traditional in vitro screens which require extensive resources and time. Therefore, integration of in silico screens prior to experimental validation can improve the efficiency of pre-clinical drug development. Areas covered: This article reviews different methods and frameworks used to computationally screen for anti-leukemic agents. In particular, three approaches are discussed including molecular docking, transcriptomic integration, and network analysis. Expert opinion: Today's data deluge presents novel opportunities to develop computational tools and pipelines to screen for likely therapeutic candidates in the treatment of leukemia. Formal integration of these methodologies can accelerate and improve the efficiency of modern day anti-leukemic drug discovery and ease the economic and healthcare burden associated with it.
a Department of Molecular and Systems Biology , Geisel School of Medicine at Dartmouth , Hanover , NH , USA.
Matthew H
MH
Ung
a Department of Molecular and Systems Biology , Geisel School of Medicine at Dartmouth , Hanover , NH , USA.
Frederick S
FS
Varn
a Department of Molecular and Systems Biology , Geisel School of Medicine at Dartmouth , Hanover , NH , USA.|b Department of Biomedical Data Science , Geisel School of Medicine at Dartmouth , Lebanon , NH , USA.|c Norris Cotton Cancer Center , Lebanon , NH , USA.
Chao
C
Cheng
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003198:Computer Simulation; D017076:Computer-Aided Design; D015195:Drug Design; D055808:Drug Discovery / Q000379:methods; D004353:Drug Evaluation, Preclinical / Q000379:methods; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000473:pathology; D062105:Molecular Docking Simulation
D000970:Antineoplastic Agents
Computational drug repositioning; leukemia; molecular docking; network analysis; transcription profiling
Am J Hematol. 2015 May;90(5):446-60
25908509
Nat Genet. 2013 Aug;45(8):868-76
23770605
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
16199517
Blood. 2013 Dec 5;122(24):3899-907
24041576
Blood. 2009 May 28;113(22):5575-82
19299336
N Engl J Med. 2015 Sep 17;373(12):1136-52
26376137
J Biol Chem. 2015 Jun 5;290(23):14441-53
25847249
Trends Pharmacol Sci. 2011 Oct;32(10):623-30
21862141
Mol Cancer Ther. 2015 Aug;14(8):1777-93
26026053
Nat Rev Cancer. 2005 Apr;5(4):311-21
15803157
BMC Bioinformatics. 2007 Nov 16;8:452
18021409
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
10592235
Curr Protoc Chem Biol. 2012 Sep;4:193-209
26609498
Comb Chem High Throughput Screen. 2004 Dec;7(8):757-61
15578937
Nucleic Acids Res. 2013 Jan;41(Database issue):D955-61
23180760
Nat Rev Genet. 2004 Feb;5(2):101-13
14735121
BMC Genomics. 2014;15 Suppl 4:S5
25057111
Eur J Med Chem. 2010 Nov;45(11):5183-99
20843586
PLoS Comput Biol. 2012 Feb;8(2):e1002347
22346740
Blood. 2015 Jan 22;125(4):680-6
25468567
Contemp Oncol (Pozn). 2015;19(1A):A68-77
25691825
Blood. 2008 Mar 1;111(5):2505-15
18299451
Leukemia. 2010 Jul;24(7):1265-75
20508621
PLoS Comput Biol. 2013;9(5):e1003054
23717195
CPT Pharmacometrics Syst Pharmacol. 2015 Jul;4(7):415-25
26312165
PLoS Genet. 2011 Jan 13;7(1):e1001273
21249183
Cancer Cell. 2006 Oct;10(4):331-42
17010674
Lancet Oncol. 2010 Nov;11(11):1096-106
20947430
Sci Rep. 2015 Nov 24;5:16987
26598031
Curr Comput Aided Drug Des. 2011 Jun;7(2):146-57
21534921
Cell. 2012 Jul 20;150(2):264-78
22817890
Blood. 2011 Jun 23;117(25):6906-11
21540461
Blood. 2015 Jul 23;126(4):471-7
26065659
Nat Genet. 2015 Jun;47(6):672-6
25961940
Curr Comput Aided Drug Des. 2011 Mar;7(1):10-22
20807187
Nat Med. 2011 Aug 28;17(9):1086-93
21873988
Nat Genet. 2014 Jan;46(1):56-60
24292274
Blood. 2008 Jun 15;111(12 ):5654-62
18305216
J Am Med Inform Assoc. 2016 Jul;23(4):681-91
27026610
Nat Rev Genet. 2013 Oct;14(10):719-32
24045689
Genes Dev. 2007 May 1;21(9):1010-24
17473168
Science. 2015 Feb 20;347(6224):1257601
25700523
J Chem Inf Model. 2016 Mar 28;56(3):527-34
26914852
Pharmacogenomics J. 2016 Mar 15;:
26975228
Blood. 2010 Dec 23;116(26):5983-90
20889920
Blood. 1988 Aug;72(2):567-72
3165295
Nat Rev Dis Primers. 2016 Mar 10;2:16010
27159408
Nat Rev Drug Discov. 2004 Nov;3(11):935-49
15520816
J Clin Oncol. 2016 Jun 20;34(18):2133-40
27114598
BMC Med. 2013 May 09;11:124
23656622
Cell. 2008 Feb 22;132(4):631-44
18295580
Nucleic Acids Res. 2016 Jan 4;44(D1):D1202-13
26400175
Drug Discov Today. 2014 May;19(5):637-44
24239728
Science. 2006 Sep 29;313(5795):1929-35
17008526
Leukemia. 2002 Apr;16(4):520-6
11960328
Nature. 2013 Oct 17;502(7471):333-9
24132290
Interdiscip Sci. 2016 Sep;8(3):241-52
26297311
Sci Rep. 2016 Jun 30;6:29228
27356765
Nucleic Acids Res. 2002 Jan 1;30(1):163-5
11752281
Nat Methods. 2013 Dec;10(12):1209-10
24122041
Oncogene. 2001 Oct 29;20(49):7140-5
11704842
Sci Rep. 2014 Nov 10;4:6948
25382104
Nucleic Acids Res. 2014 Jan;42(Database issue):D1091-7
24203711
J Chem Inf Model. 2012 Jul 23;52(7):1757-68
22587354
Sci Rep. 2015 Jun 29;5:11702
26118648
Drug Discov Today. 2009 Jul;14(13-14):676-83
19422931